Bugia, L., Jungbauer, F., Zaubitzer, L., Hörner, C., Merx, K., Yasser, A., . . . Affolter, A. (2024). Nivolumab as a promising treatment option for metastatic salivary duct carcinoma. Journal of immunotherapy, 47(7), . https://doi.org/10.1097/CJI.0000000000000513
Chicago-Zitierstil (17. Ausg.)Bugia, Luis, et al. "Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma." Journal of Immunotherapy 47, no. 7 (2024). https://doi.org/10.1097/CJI.0000000000000513.
MLA-Zitierstil (9. Ausg.)Bugia, Luis, et al. "Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma." Journal of Immunotherapy, vol. 47, no. 7, 2024, https://doi.org/10.1097/CJI.0000000000000513.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.